Material therapy

The development of so-called photodynamic therapy uses lasers for treatment of cancer. The patient is injected with a substance called hematoporphyrin derivative [68335-15-9] which is preferentially localized in cancerous tissues. The patient is later irradiated with laser light, often with a dye laser at a wavelength around 630 nm. The light energy catalyticaHy photooxidizes the hematoporphyrin derivative, releasing materials which kill the nearby cancerous tissue. Normal tissue which did not retain the chemical is not harmed. Photodynamic therapy offers promise as a new form of cancer treatment. 

Use of coherent light sources in industrial appHcations has led to the field of photodynamic therapy as a photochemically based medical technology (9—11). The apphcation of photochemistry to information storage and communication processes is expected (12) (see Information storage materials Resist materials). 

Ca.rhora.nes, These are used in neutron capture therapy (254), and as bum rate modifiers in gun and rocket propellants. They are used as high temperature elastomers and other unique materials, high temperature gas—Hquid chromatography stationary phases, optical switching devises (256), and gasoline additives (257). 

The success of thrombus lysis depends mainly on how large the thrombus is and whether any blood flow stiU remains. The outcome is better the larger the surface of the entire thrombus exposed to the thrombolytic agent. As the clot ages, the polymerization of fibria cross-linking and other blood materials iacreases and it becomes more resistant to lysis. Therefore, the eadier the thrombolysis therapy starts, the higher the frequency of clot dissolution. Thrombolytic agents available are Hsted ia Table 7 (261—276). 

Functional dyes (1) of many types are important photochemical sensitizers for oxidation, polymerization, (polymer) degradation, isomerization, and photodynamic therapy. Often, dye stmctures from several classes of materials can fulfiH a similar technological need, and reviewing several dye stmctures... 

There is a risk of acute renal failure when iodi-nated contrast material that is used for radiological studies is administered with metformin. Metformin therapy is stopped for 48 hours before and after radiological studies using iodinated material. Alcohol, amiloride, digoxin, morphine, procainamide, quini-dine, quinine ranitidine, triamterene, trimethoprim, vancomycin, cimetidine, and furosemide all increase the risk of hypoglycemia. There is an increased risk of lactic acidosis when metformin is administered with the glucocorticoids. 

Brekke, J. H., Bresner, M., and Reitman, M. J., Polylactic acid surgical dressing material. Postoperative therapy for dental extraction wounds. Can. Dent. Assoc. J., 52, 599,... 

The stndy and preparation of hollow capsules has attracted considerable attention in recent years. Hollow capsules are of immense interest in a long list of potential applications. These inclnde drug delivery, gene therapy, catalysis, waste removal, acoustic insulation, piezoelectric transducers, and functional materials [14],... 

This book, which incorporates materials written by some of the finest minds in pharmacy practice and education, can enable the reader to play a crucial role in improving the drug use process for patients, providers, payers, and society. The purpose of this book is to help hone your skills so you can make a real improvement in the therapies you provide to your patients. Current and future clinicians can rely on the information laid out here to enhance your knowledge and allow you to assist your patients with the sound advice that they expect you to provide. Use the text, case histories, and numerous examples detailed here to expand your therapeutic skills, and to help positively impact your patients in the years to come. 

Inform patient about the effects of vitamin K-rich foods on warfarin therapy. Moderate intake (less than 500 to 1000 meg) of vitamin K is acceptable. Provide patient with written material regarding vitamin K content of foods. 

While selection of antimicrobial therapy may be a major consideration in treating infectious diseases, it may not be the only therapeutic intervention. Other important therapies may include adequate hydration, ventilatory support, and other supportive medications. In addition, antimicrobials are unlikely to be effective if the process or source that leads to the infection is not controlled. Source control refers to this process and may involve removal of prosthetic materials such as catheters and infected tissue or drainage of an abscess. Source-control considerations should be a fundamental component of any infectious diseases treatment. It is also important to recognize that there may be many different antimicrobial regimens that may cure the patient. While the following therapy sections... 

It is important to determine (1) whether the isolate is methicillin-susceptible or methicillin-resistant and (2) whether the patient has a prosthetic valve. For patients with no prosthetic material, methicillin-susceptible staphylococci treatment should consist of a penicillinase-resistant penicillin (e.g., nafcillin or oxacillin) with or without gentamicin, and for methicillin-resistant strains, therapy should consist of vancomycin (see Table 71-4). Combination therapy with aminoglycosides, when used in these patients, typically is given only during the first 3 to 5 days of therapy. In the absence of prosthetic material, some treatment guidelines do not recommend combination therapy against MRSA. However, many clinicians may combine either gentamicin or rifampin with vancomycin if the patient is unresponsive to monotherapy. 

TABLE 71-4. Therapy for Endocarditis Caused by Staphylococci in the Absence of Prosthetic Materials... 

Brachytherapy A procedure in which radioactive material, sealed in needles, seeds, wires, or catheters, is placed directly into or near a tumor. Also called internal radiation, implant radiation, or interstitial radiation therapy. 

Polynucleotides. Polynucleotides are potent interferon inducers. A mismatched, double-stranded synthetic polyribonucleotide ampligen and the double-stranded acids, polyadenylic-polyuridylic acid and polyinosinic-polycytidylic acids have been widely studied for cancer therapy(ii). Although these materials elicit excellent activity with murine rodents, therapeutic effects are dramatically decreased within primates. 

---